- About this Journal ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2013 (2013), Article ID 829486, 10 pages
Clinical Stages in Patients with Primary and Subsequent Cancers Based on the Czech Cancer Registry 1976–2005
1Department of Science and Research, University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic
2Laboratory on Geoinformatics and Cartography, Department of Geography, Faculty of Science, Masaryk University, Kotlarska 2, 611 37 Brno, Czech Republic
3Department of Internal Medicine, University Hospital Brno, Pekarska 53, 602 00 Brno, Czech Republic
4Department of Surgery, University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic
Received 13 April 2013; Accepted 9 June 2013
Academic Editors: N. Fujimoto, O. Hansen, R. Nahta, K. Sonoda, M. Stracke, and K. van Golen
Copyright © 2013 Edvard Geryk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- IARC, “Globocan,” Lyon, France, IARC, 2008, http://globocan.iarc.fr/.
- IHIS, Cancer incidence in the Czech Republic. Health statistics, editorial series, http://www.uzis.com/.
- “Twenty-five years of the Czech Association for combat and exploration of malignant tumors in Prague,” Prague, Czech Republic, 1930.
- J. Weiss, “Contribution to the statistics of the cancer increasing,” Practical Medicine, vol. 22, article 617, 1933.
- M. Konečný, E. Geryk, P. Kubíček, et al., Cancer Prevalence in the Czech Republic, 1989-2005-2015, vol. 69, Masaryk University, Brno, Czech Republic, 2008.
- E. Geryk, P. Dítě, J. Kozel, et al., “Cancer multiplicites in the Czech population,” Casopís Lékařů Českých, vol. 149, no. 4, pp. 178–183, 2010 (Czech).
- E. Geryk, M. Bendová, and J. Kozel, “Breast cancer and subsequent primary malignant neoplasms in the Czech Republic 1976–2005,” Oncology, vol. 3, no. 1, pp. 54–61, 2009 (Czech).
- E. Geryk, P. Dítě, L. Sedláková, et al., “Trends of multiple non-melanoma skin cancers in a view of their epidemiology,” Practice Dermatology, vol. 4, no. 1, pp. 5–9, 2010 (Czech).
- E. Geryk, P. Dítě, J. Kozel, et al., “Other primary neoplasms in patients with prostate cancer in comparison of its incidence, mortality and prevalence,” Oncology, vol. 4, no. 2, pp. 89–93, 2010 (Czech).
- P. Dítě and E. Geryk, “Trends of primary and subsequent cancers of the gastrointestinal tract in the czech population, 1976–2005,” Digestive Diseases, vol. 28, no. 4-5, pp. 657–669, 2010.
- E. Geryk, J. Kozel, R. Štampach et al., “Multiple cancers of nervous system and other primary neoplasms,” Oncology, vol. 5, no. 3, pp. 175–180, 2011 (Czech).
- T. Horvath, E. Geryk, J. Kozel, et al., “Lung cancer in multiple malignant neoplasms,” in Proceedings of the 3rd Lung Cancer Conference, Geneva, Switzerland, 2012.
- E. Geryk, J. Kozel, T. Horváth, et al., “Patients with multiple cancers of head and neck,” Oncology, vol. 6, no. 5, pp. 260–265, 2012 (Czech).
- E. Geryk, J. Kozel, D. Pacík, R. Štampach, and T. Horváth, “Multiple cancers of testis,” Practice Urology, vol. 14, no. 1, pp. 34–38, 2013 (Czech).
- E. Geryk, D. Pacik, J. Kozel, et al., “Penile cancers associated with occurrence of other neoplasms,” Urology Letters, vol. 10, no. 4, pp. 1–6, 2012 (Czech).
- E. Geryk, P. Koška, P. Dítě, et al., “Cancers, health and economy: parts of Pandoras box?” Oncology, vol. 7, no. 1, pp. 314–320, 2013 (Czech).
- R. E. Curtis, D. M. Freedman, E. Ron, et al., New Malignancies Among Cancer Survivors: SEER Cancer Registries 1973–2000, National Cancer Institute, Bethesda, Md, USA, 2006.
- ACS, “Multiple primary cancers,” in Cancer Facts and Figures 2009, pp. 24–41, American Cancer Society, Atlanta, Ga, USA, 2009.
- T. Billroth and A. von Winiwarer, Die Allgemeine Chirurgische Patologie Und Therapie, G. Reimer, Berlin, Germany, 1889.
- J. M. Holland, A. Arsanjani, B. J. Liem, S. Christopher Hoffelt, J. I. Cohen, and K. R. Stevens, “Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy,” Journal of Laryngology and Otology, vol. 116, no. 3, pp. 190–193, 2002.
- N. N. Baxter, J. E. Tepper, S. B. Durham, D. A. Rothenberger, and B. A. Virnig, “Increased risk of rectal cancer after prostate radiation: a population-based study,” Gastroenterology, vol. 128, no. 4, pp. 819–824, 2005.
- M. Clarke, R. Collins, S. Darby, et al., “Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 366, no. 9503, pp. 2087–2106, 2005.
- C. Rubino, A. Shamsaldin, M. G. Lê et al., “Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment,” Breast Cancer Research and Treatment, vol. 89, no. 3, pp. 277–288, 2005.
- P. Valagussa, A. Moliterni, M. Terenziani, M. Zambetti, and G. Bonadonna, “Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer,” Annals of Oncology, vol. 5, no. 9, pp. 803–808, 1994.
- J. M. Kaldor, N. E. Day, B. Kittelmann et al., “Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study,” International Journal of Cancer, vol. 63, no. 1, pp. 1–6, 1995.
- L. B. Travis, M. Gospodarowicz, R. E. Curtis, et al., “Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease,” Journal of the National Cancer Institute, vol. 94, no. 3, pp. 182–192, 2002.
- R. E. Curtis, D. M. Freedman, M. E. Sherman, and J. F. Fraumeni Jr., “Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer,” Journal of the National Cancer Institute, vol. 96, no. 1, pp. 70–74, 2004.
- A. J. Swerdlow, M. E. Jones, D. H. Brewster et al., “Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study,” Journal of the National Cancer Institute, vol. 97, no. 5, pp. 375–384, 2005.
- C. K. Fairley, A. G. R. Sheil, J. J. McNeil et al., “The risk of ano-genital malignancies in dialysis and transplant patients,” Clinical Nephrology, vol. 41, no. 2, pp. 101–105, 1994.
- S. A. Birkeland, H. H. Storm, L. U. Lamm et al., “Cancer risk after renal transplantation in the nordic countries, 1964–1986,” International Journal of Cancer, vol. 60, no. 2, pp. 183–189, 1995.
- R. E. Curtis, P. A. Rowlings, H. J. Deeg et al., “Solid cancers after bone marrow transplantation,” The New England Journal of Medicine, vol. 336, no. 13, pp. 897–904, 1997.
- S. Euvrard, J. Kanitakis, and A. Claudy, “Skin cancers after organ transplantation,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1681–1691, 2003.
- T. Kirchhoff, N. D. Kauff, N. Mitra et al., “BRCA mutations and risk of prostate cancer in Ashkenazi jews,” Clinical Cancer Research, vol. 10, no. 9, pp. 2918–2921, 2004.
- H. D. Nelson, L. H. Huffman, R. Fu, and E. L. Harris, “Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force,” Annals of Internal Medicine, vol. 143, no. 5, pp. 326–379, 2005.
- R. S. Ostfeld, G. E. Glass, and F. Keesing, “Spatial epidemiology: an emerging (or re-emerging) discipline,” Trends in Ecology and Evolution, vol. 20, no. 6, pp. 328–336, 2005.
- M. Konečný and W. Reinhardt, “Early warning and disaster management: the importance of geographic information,” International Journal of Digital Earth, vol. 3, no. 3, pp. 217–220, 2010.
- R. Štampach, K. Konečný, et al., “Dynamic cartographic methods for visualization of health statistics,” in Cartography in Central and Eastern Europe, pp. 431–442, Springer, Berlin, Germany, 2010.